These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19221791)

  • 21. Bone marrow micrometastases detected by RT-PCR for mammaglobin can be an alternative prognostic factor of breast cancer.
    Ooka M; Tamaki Y; Sakita I; Fujiwara Y; Yamamoto H; Miyake Y; Sekimoto M; Ohue M; Sugita Y; Miyoshi Y; Ikeda N; Noguchi S; Monden M
    Breast Cancer Res Treat; 2001 May; 67(2):169-75. PubMed ID: 11519865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer.
    Benoy IH; Elst H; Philips M; Wuyts H; Van Dam P; Scharpé S; Van Marck E; Vermeulen PB; Dirix LY
    Br J Cancer; 2006 Mar; 94(5):672-80. PubMed ID: 16495933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue.
    Vlems FA; Diepstra JH; Cornelissen IM; Ruers TJ; Ligtenberg MJ; Punt CJ; van Krieken JH; Wobbes T; van Muijen GN
    Mol Pathol; 2002 Jun; 55(3):156-63. PubMed ID: 12032226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of alternatively spliced c-erbB-2 mRNA in primary tumors, lymph node metastases, and bone marrow micrometastases from breast cancer patients.
    Gebhardt F; Zänker KS; Brandt B
    Biochem Biophys Res Commun; 1998 Jun; 247(2):319-23. PubMed ID: 9642124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of MUC1 and EGP40 in bone marrow and peripheral blood as a marker for occult breast cancer.
    Zhong XY; Kaul S; Bastert G
    Arch Gynecol Obstet; 2001 Jan; 264(4):177-81. PubMed ID: 11205703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reverse transcriptase/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer.
    Wulf GG; Jürgens B; Liersch T; Gatzemeier W; Rauschecker H; Buske C; Hüfner M; Hiddemann W; Wörmann B
    J Cancer Res Clin Oncol; 1997; 123(9):514-21. PubMed ID: 9341902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of a panel of novel genes for differentiating breast cancer from non-breast tissues.
    O'Brien N; O'Donovan N; Foley D; Hill AD; McDermott E; O'Higgins N; Duffy MJ
    Tumour Biol; 2007; 28(6):312-7. PubMed ID: 18253069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow.
    Cabioglu N; Sahin A; Doucet M; Yavuz E; Igci A; O Yildirim E; Aktas E; Bilgic S; Kiran B; Deniz G; Price JE
    Clin Exp Metastasis; 2005; 22(1):39-46. PubMed ID: 16132577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Micrometastasis of bone marrow as a prognostic factor of breast cancers].
    Takeyama H; Inoue H; Yamazaki Y
    Nihon Rinsho; 2000 Apr; 58 Suppl():460-5. PubMed ID: 11026034
    [No Abstract]   [Full Text] [Related]  

  • 30. Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients.
    Duchnowska R; Jassem J; Goswami CP; Dundar M; Gökmen-Polar Y; Li L; Woditschka S; Biernat W; Sosińska-Mielcarek K; Czartoryska-Arłukowicz B; Radecka B; Tomasevic Z; Stępniak P; Wojdan K; Sledge GW; Steeg PS; Badve S
    J Neurooncol; 2015 Mar; 122(1):205-16. PubMed ID: 25559688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolated tumor cells in the bone marrow (ITC-BM) of breast cancer patients before and after anthracyclin based therapy: influenced by the HER2- and Topoisomerase IIalpha-status of the primary tumor?
    Schindlbeck C; Janni W; Shabani N; Kornmeier A; Rack B; Rjosk D; Gerber B; Braun S; Sommer H; Friese K
    J Cancer Res Clin Oncol; 2005 Aug; 131(8):539-46. PubMed ID: 15887027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of micrometastatic cells in breast cancer by RT-pCR for the mammaglobin gene.
    Bossolasco P; Ricci C; Farina G; Soligo D; Pedretti D; Scanni A; Deliliers GL
    Cancer Detect Prev; 2002; 26(1):60-3. PubMed ID: 12088204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of disseminated tumor cells in the bone marrow of breast cancer patients with a new molecular method].
    Banyś M; Krawczyk N; Becker S; Becker-Pergola G; Banyś J; Krawczyk Z; Wallwiener D; Fehm T
    Ginekol Pol; 2012 Aug; 83(8):590-7. PubMed ID: 23342882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of bone marrow micrometastasis and microcirculating disease in rhabdomyosarcoma by a real-time RT-PCR assay.
    Gallego S; Llort A; Roma J; Sabado C; Gros L; de Toledo JS
    J Cancer Res Clin Oncol; 2006 Jun; 132(6):356-62. PubMed ID: 16435141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer.
    Benoy IH; Elst H; Philips M; Wuyts H; Van Dam P; Scharpé S; Van Marck E; Vermeulen PB; Dirix LY
    Clin Breast Cancer; 2006 Jun; 7(2):146-52. PubMed ID: 16800974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patients.
    van Wezel EM; Decarolis B; Stutterheim J; Zappeij-Kannegieter L; Berthold F; Schumacher-Kuckelkorn R; Simon T; Fiocco M; van Noesel MM; Caron HN; van der Schoot CE; Hero B; Tytgat GAM
    Eur J Cancer; 2016 Feb; 54():149-158. PubMed ID: 26796600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New methods to improve the safety assessment of cryopreserved ovarian tissue for fertility preservation in breast cancer patients.
    Rodríguez-Iglesias B; Novella-Maestre E; Herraiz S; Díaz-García C; Pellicer N; Pellicer A
    Fertil Steril; 2015 Dec; 104(6):1493-502.e1-2. PubMed ID: 26364839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of a panel of mRNA markers in the detection of disseminated tumor cells in patients with operable breast cancer.
    Varangot M; Barrios E; Sóñora C; Aizen B; Pressa C; Estrugo R; Lavigna R; Musé I; Osinaga E; Berois N
    Oncol Rep; 2005 Aug; 14(2):537-45. PubMed ID: 16012742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patients.
    Gilje B; Nordgård O; Tjensvoll K; Borgen E; Synnestvedt M; Smaaland R; Naume B
    BMC Cancer; 2014 Jul; 14():514. PubMed ID: 25023626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular detection of disseminated breast cancer cells in the bone marrow of early breast cancer patients using quantitative RT PCR for CEA.
    Janku F; Srovnal J; Korinkova G; Novotny J; Petruzelka L; Power D; Matous B; Hajduch M
    Neoplasma; 2008; 55(4):317-22. PubMed ID: 18505343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.